Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Terns Pharmaceuticals, Inc. | StockGist | StockGist

Companies
TERN
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings TERNSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Terns Pharmaceuticals, Inc.

Filed Feb 13, 2026

Accepted Feb 12, 2026, 7:00 PM ET

CIK 0001831363

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

106,198,970

Reporting Person

Terns Pharmaceuticals, Inc.

Person Type

PN

CUSIP: 880881107

Amendment History

5 filings

SCHEDULE 13G
Original
Feb 12, 20260000902664-26-000916
SCHEDULE 13G/A
Amendment 1
Feb 12, 20260001213900-26-015655
SCHEDULE 13G/A
Amendment 2
Viewing
Feb 13, 20260001213900-26-016651
SCHEDULE 13G/A
Amendment 3
Feb 13, 20260001172661-26-000722
SCHEDULE 13G/A
Amendment 4
Latest
Feb 17, 20260001831942-26-000009

Key Facts

Shares Owned

106,198,970

Recent Filings

Terns Pharmaceuticals, Inc.1 weeks ago

Terns Pharmaceuticals, Inc.1 weeks ago

Terns Pharmaceuticals, Inc.1 months ago

Terns Pharmaceuticals, Inc.1 months ago

Terns Pharmaceuticals, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice